United Therapeutics

Highly Engaged Employees

United Therapeutics, trading under NASDAQ: UTHR, is a prominent global contract development and manufacturing organization (CDMO) founded in 1996. The company specializes in the production of single-dose liquid pharmaceuticals and sterile unit-dose formats for the pharmaceutical and consumer healthcare sectors. It is a recognized world leader in blow-fill-seal technology, an advanced aseptic manufacturing process that ensures high sterility and product integrity through automated container formation, filling, and sealing. Unither's expertise spans the development and manufacturing of diverse liquid dosage forms, including oral solutions, suspensions, nasal sprays, and eye drops, delivered in innovative single-dose formats. The company serves a broad client base comprising pharmaceutical companies, biotechnology firms, and consumer health brands, offering comprehensive services from formulation development and clinical trial manufacturing to large-scale commercial production and packaging. With a global operational footprint including manufacturing facilities across Europe and North America, United Therapeutics adheres to stringent quality standards and regulatory compliance with international pharmaceutical guidelines, including FDA and EMA requirements. The company is committed to innovation in drug delivery systems and patient convenience, supporting clients in bringing their pharmaceutical products to market efficiently. Learn about United Therapeutics' global headquarters for detailed geographic information on its operational sites. The organization employs between 1,000 and 5,000 individuals, contributing to its extensive capabilities. Meet United Therapeutics' team to understand the leadership driving its strategic initiatives. With a reported revenue of $3.2B, United Therapeutics demonstrates significant market presence and financial strength within the specialized CDMO segment. Explore financial highlights for a deeper dive into its fiscalView more...